With millions of Americans now using semaglutide, tirzepatide, and related therapies, RDNs are encountering new patterns of appetite suppression, food aversions, reduced portion tolerance, digestive sensitivities, and changing attitudes toward alcohol, indulgence, and social eating
Some doctors offices have staff dedicated to insurance authorizations who are experienced in what documentation succeeds with different insurance companies
All patients receive a custom diet and exercise plan included in their program
The same clear pattern was, however, not observed in the food-effect trial, as SNAC exposure was not increased in the fed arm
We recommend discussing glutathione safety with your primary care provider separately